<DOC>
	<DOCNO>NCT00374920</DOCNO>
	<brief_summary>The purpose study establish potential MEM 1003 safe effective treatment patient acute manic mixed episode bipolar disorder .</brief_summary>
	<brief_title>Safety Efficacy MEM 1003 Versus Placebo Treatment Patients With Bipolar I Disorder</brief_title>
	<detailed_description>Bipolar affective disorder one common , severe , persistent mental illness . It characterize period deep , prolong , profound depression alternate period excessively elevate and/or irritable mood ( mania ) . The pathophysiology bipolar disorder complex , include inheritable component , administration antidepressant medication , behavioral sensitization process , neuronal calcium dysregulation lead apoptosis critical brain circuitry regulate emotion . Addressing dysregulation calcium level central nervous system administer compound MEM 1003 may potential alter cyclical course progression bipolar disorder . MEM 1003 ( + ) -enantiomer dihydropyridine optimized central nervous system activity . It inhibit L-type Ca2+ channel within anticipated human dose range benign cardiovascular effect DHP L-Type calcium channel modulators .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>bipolar I disorder acute manic mixed episode , without psychotic feature YMRS score least 20 history least one previous manic mixed episode require treatment last 10 year history fail respond treatment two adequate trial approve antimanic medication current episode Axis I Axis II disorder ( bipolar I disorder ) require treatment primary subject treatment past 3 month define substance abuse dependency within 3 month schizophrenia , schizoaffective disorder , delusional disorder , mental retardation pervasive developmental disorder suicidal danger others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>bipolar</keyword>
	<keyword>mania</keyword>
	<keyword>mixed</keyword>
</DOC>